期刊文献+

加拿大药物经济学评价准则的发展及其启示 被引量:5

On the Development and Edification of Canadian Guidelines for the Pharmacoeconomic Evaluation
下载PDF
导出
摘要 目的 :提出规范药物经济学研究的建议。方法 :对加拿大药物经济学评价准则制定的背景和主要内容进行了介绍 ,并阐述了其最新发展状况 ,同时对我国药物经济学评价标准的初步建构提出了自己的设想。结果与结论 :应建立一套为国家社会保障部门、药品监督管理部门、卫生行政部门所认可的药物经济学的评价准则 ,规范药物经济学研究。同时 ,政府应出台相应政策 ,将药物经济学评价和药品价格、临床合理用药、《药品分类管理目录》、《社会医疗保险用药目录》等问题联系起来 。 AIM:To put forward the suggestions for standardizing the pharmacoeconomic research.METHODS:The background of formulation and main points of Canadian Guidelines for the Pharmacoeconomic Evaluation were introduced and its recent development was described.At the same time,we put forward our tentative plan about establishing Chinese guidelines for the pharmacoeconomic evaluation.RESULTS & CONCLUSION:A series of guidelines for the pharmacoeconomic evaluation should be established,which is approved by departments of social safeguard,drug supervision and public health administration,to standardize the pharmacoeconomic research.The goverment should make corresponding policy publicized and make pharmacoeconomic evaluation connect with drug price,clinically rational drug use,catalog of classified management of drugs and catalog of drugs in medical insurance.A pharmacoeconomic framework,which conforms China's national conditions and is controlled by goverment,will established.
出处 《中国药房》 CAS CSCD 2001年第3期138-140,共3页 China Pharmacy
关键词 药物经济学 评价准则 加拿大 pharmacoeconomics evaluation guideline Canada
  • 引文网络
  • 相关文献

参考文献7

  • 1何志高,张钧,陈征宇,陈盛新.关于在我国开展药物经济学研究的思考[J].中国药房,1999,10(2):73-75. 被引量:15
  • 2CanadianCoordinatingOfficeforHealthTechnology Assessment.Guidelinesforeconomicevaluationofpha-rmaceuticals[M].Canada.Ottawa:CCOHTA,1994.
  • 3TorranceGW.Canadianguidelinesforeconomicevalu- ationofpharmaceuticals[J].Pharmacoeconomics,1996,9(6):535.
  • 4TorranceGW.Framinganddesigningthecost-effecti- venessanalysis:cost-effectivenessinhealthandmedic-ine[C].NewYork:OxfordUniversityPress,1996:54.
  • 5AnisAH.Usingpharmacoeconomicanalysistomake druginsurancecoveragedecisions[J].Pharmacoecono-mics,1998,13(1~2):119.
  • 6IkedaS,IkegamiN,OliverAj,etal.Acaseforthea-doptionofpharmacoeconomicguidelinesinJapan[J] Pharmacoeconomics,1996,10(6):546.
  • 7Aladi JF,Menon D,Otten N。Use of economic evaluation guidelines: 2 Years‘experience in Canada[J]。 Health Economics,1998,7(3):221。

二级参考文献2

共引文献14

同被引文献80

引证文献5

二级引证文献39

;
使用帮助 返回顶部